A/ End-joining assay under standard reaction conditions with HeLa cell extracts, in the presence or not of DNA-PK specific inhibitor NU7441 (DNA-PKi) and ssO at the indicated concentration. DNA ligation products were separated by agarose gel electrophoresis followed by SYBR-Green staining. B/ End-joining assay with extracts from HCT116 Lig4 -/-cells, in the presence or not of DNA-PK specific inhibitor NU7441 (DNA-PKi) and ssO at the indicated concentration. C/ End-joining assay with extracts from HCT116 Lig4 -/-cells, in the
presence or not of DNA-PK specific inhibitor NU7441 (DNA-PKi) and 4 µM of ssO or dsO, as indicated. D/ End-joining assay with extracts from HeLa or HCT116 cells and linearized pDVG plasmid, in the presence or not of DNA-PK specific inhibitor NU7441 (DNA-PKi) and ssO, as indicated. E/ Junction characterization after end-joining of linearized pDVG94 plasmid with extracts wild-type or Lig4 -/-HCT116 cells. After ligation, plasmids were purified, the junction was PCR-amplified and digested by BstXI. Digestion products were separated by acrylamide gel electrophoresis followed by SYBR-Green staining. % recruitment
